Preliminary results of a phase 1A/1B study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb), in patients with advanced hepatocellular carcinoma (HCC)

Chia Jui Yen; Benjamin Markman; Yee Chao; Andrew Hill; Jinyu Kang; Lai Wang; Kang Li; Qinzhou Qi; Zhong Wu; Hui Gan

doi:10.1093/annonc/mdx261.139

Preliminary results of a phase 1A/1B study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb), in patients with advanced hepatocellular carcinoma (HCC)

Chia Jui Yen, Benjamin Markman, Yee Chao, Andrew Hill, Jinyu Kang, Lai Wang, Kang Li, Qinzhou Qi, Zhong Wu, Hui Gan

Department of Oncology

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	iii54
Journal	Annals of Oncology
Volume	28
DOIs	https://doi.org/10.1093/annonc/mdx261.139
Publication status	Published - 2017 Jun

All Science Journal Classification (ASJC) codes

Hematology
Oncology

Access to Document

10.1093/annonc/mdx261.139

Cite this

@article{7a9fc1eb8cfe4f92b3e32fe347e8eeb9,

title = "Preliminary results of a phase 1A/1B study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb), in patients with advanced hepatocellular carcinoma (HCC)",

author = "Yen, {Chia Jui} and Benjamin Markman and Yee Chao and Andrew Hill and Jinyu Kang and Lai Wang and Kang Li and Qinzhou Qi and Zhong Wu and Hui Gan",

year = "2017",

month = jun,

doi = "10.1093/annonc/mdx261.139",

language = "English",

volume = "28",

pages = "iii54",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Preliminary results of a phase 1A/1B study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb), in patients with advanced hepatocellular carcinoma (HCC)

AU - Yen, Chia Jui

AU - Markman, Benjamin

AU - Chao, Yee

AU - Hill, Andrew

AU - Kang, Jinyu

AU - Wang, Lai

AU - Li, Kang

AU - Qi, Qinzhou

AU - Wu, Zhong

AU - Gan, Hui

PY - 2017/6

Y1 - 2017/6

UR - http://www.scopus.com/inward/record.url?scp=85072093158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072093158&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdx261.139

DO - 10.1093/annonc/mdx261.139

M3 - Article

C2 - 32135938

SN - 0923-7534

VL - 28

SP - iii54

JO - Annals of Oncology

JF - Annals of Oncology

ER -

Preliminary results of a phase 1A/1B study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb), in patients with advanced hepatocellular carcinoma (HCC)

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this